Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure its key ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

North Carolina economic development officials have terminated an economic incentives agreement for Novartis Gene Therapies, ...

Platinum Asset Management’s flagship international fund initiated positions in several pharmaceutical companies in the ...

Two days after pharma companies sounded an alarm that their investments were headed out of Europe, Novartis AG has announced ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Novartis (NVS) plans to invest $23B in U.S. facilities over the next five years, creating 13K+ jobs amid tariff threats. Read ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

J.P. Morgan analyst Richard Vosser reiterated a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF95.00.

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...